Michael Dale is recorded as CEO and Board Member at Axogen, Inc. (AXGN). The newest filing on record that lists Michael Dale as CEO and Board Member at Axogen, Inc. (AXGN) is dated April 29, 2026. Axogen, Inc. reported in an 8-K filed August 9, 2024 that Michael Dale was appointed member of the Board, effective August 9, 2024. Axogen, Inc. reported in an 8-K filed August 9, 2024 that Michael Dale was appointed Chief Executive Officer, effective August 9, 2024. The proxy statement of Axogen, Inc. reports total compensation of $9,047,454 for Michael Dale in fiscal 2025, including a base salary of $775,865. Disclosed compensation is on record for 4 fiscal years. Michael Dale has spoken on 8 earnings calls and 2 other investor events across 1 company, most recently for Axogen, Inc. on September 10, 2026. Axogen, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Axogen, Inc. includes Paul G. Thomas (Chairman and Board Member), Paul Thomas (Chairman), Lindsey Hartley (CFO) and 7 others.
“The Company also announced that Mr. Dale was appointed as a member of the Board as of the Effective Date.”
Axogen, Inc. Form 8-K, filed August 9, 2024
· Read the filing
“On August 8, 2024, Axogen, Inc. (the "Company"), announced the appointment of Michael Dale as its Chief Executive Officer ("CEO") and President, effective August 9, 2024 (the "Effective Date").”
Axogen, Inc. Form 8-K, filed August 9, 2024
· Read the filing
Michael Dale on recent calls
“Today's call will start with an overview of the transaction we announced this morning. Lindsay will then walk through the financial terms. Following our prepared remarks, we will open the call to questions.”
“Today, I will walk you through our second quarter performance using the same lens we've used all year, which are the six priorities that comprise our strategic plan.”
“We are in the process of trying to digest, to quantify it, because as you might appreciate, it's a question that's on everyone's mind, including ours. And I know this is a trite answer.”
“What I would like to do today is walk through our first quarter 2026 performance through the lens of the six priority areas of our strategic plan, sharing with you how we executed against each one of those during the quarter.”
“Today I'll walk through our fourth quarter and full year 2025 performance through the lens of the six priority areas of our strategic plan, highlighting how we executed against each in 2025 and how they frame our objectives for 2026.”
